Results 191 to 200 of about 3,523 (219)
Some of the next articles are maybe not open access.
Letermovir: First Global Approval
Drugs, 2017Letermovir (Prevymis™) is an orally or intravenously administered cytomegalovirus (CMV) DNA terminase complex inhibitor being developed by Merck & Co., Inc., under a global license from AiCuris Anti-infective Cures GmbH. Letermovir has been approved in Canada and the USA for the prophylaxis of CMV infection and disease in adult CMV-seropositive ...
openaire +2 more sources